Loading stock data…
Loading stock data…
US$4.24
Get one email when NRXP crosses your level. Checked every 15 minutes during market hours.
▼ -0.22 (-4.93%)down today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
56.6
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
0.14
Bullish momentumMACD above its signal line (0.11).
50-day average
3.78
Price aboveShort-term trend reference.
200-day average
2.76
Price aboveLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
NRx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for central nervous system disorders with high unmet medical need. The company concentrates on severe psychiatric and neurological conditions, particularly suicidal depression, suicidal bipolar depression, chronic pain, and post-traumatic stress disorder. Its pipeline is built around an NMDA-targeted platform, including NRX-100, a preservative-free intravenous ketamine formulation, an…
www.nrxpharma.com3 strong buy · 7 buy · 1 hold · 0 sell · 0 strong sell (11 analysts, 2026-07-01)
3 strong buy · 7 buy · 1 hold · 0 sell · 0 strong sell (11 analysts, 2026-06-01)
3 strong buy · 6 buy · 1 hold · 0 sell · 0 strong sell (10 analysts, 2026-05-01)
3 strong buy · 6 buy · 1 hold · 0 sell · 0 strong sell (10 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-06-16 | 1.65 | 1.67 | ✓ Beat |
| 2026-05-15 | -0.11 | -0.04 | ✓ Beat |
| 2026-04-14 | 0.44 | 0.48 | ✓ Beat |
| 2026-04-02 | -0.62 | -0.71 | ✗ Miss |
| 2026-03-20 | -0.18 | -0.15 | ✓ Beat |
Companies in the same industry, via Finnhub